Preliminary scientific tests reveal conolidine could inhibit certain ion channels, minimizing neuronal excitability and restricting discomfort signals. This system is especially pertinent in neuropathic soreness, wherever irregular signaling results in persistent pain. Moreover, conolidine appears to influence G protein-coupled receptor (GPCR) pathways integral to ache perception. Com... https://frankr013ufr8.wikiannouncement.com/user